Ruxolitinib and Decitabine for High Risk Hematological Malignancies
Clinical trial NCT04582604 · UNKNOWN
Trial details
- NCT number
- NCT04582604
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2023-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.